Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials
Ariadna Tibau, Consolación Molto, Maria Borrell, Joseph C Del Paggio, Agustí Barnadas, Christopher M Booth, Eitan Amir, Ariadna Tibau, Consolación Molto, Maria Borrell, Joseph C Del Paggio, Agustí Barnadas, Christopher M Booth, Eitan Amir
Abstract
This study uses the European Society of Medical Oncology Magnitude of Clinical Benefit Scale to evaluate the clinical benefit of anticancer drugs that gained approval by the US Food and Drug Administration based on single-arm rather than randomized clinical trials.
Conflict of interest statement
Conflict of Interest Disclosures: None reported.
Source: PubMed